Skip to main content

Clinical trials and the general practitioner

  • Conference paper
Drugs between Research and Regulations

Abstract

The process of clinical development of a new drug has so far involved the general practitioner (GP) only to a very marginal extent. Obvious safety reasons and, at least in Italy, the law prevent the GP from taking a direct part in the first phases of clinical research; on the other hand, even after the introduction of a medicine onto the market, the general practitioner’s involvement is considered to be that of prescription rather than evaluation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Basagni M, Baroni L, Lucchelli PE (1977) Diagnostic policies of minor depressive illness by two differently trained groups of general practitioners. Int.1 Clin Pharmacol 15: 474–476

    CAS  Google Scholar 

  2. Canti D, Lucchelli PE (1971) Effects of Glyvenol in relation to the dosage schedule employed (results of a large-scale trial in general practice). In: Kappert A (ed) Current aspects of chronic venous insufficiency. Ciba Geigy, Basel, p 186–200

    Google Scholar 

  3. Haines RB (1976) Strategies for improving compliances: a methodologic analysis and review. In: Sackett DL and Haines RB (eds) Compliance with Therapeutic Regimens. The Johns Hopkins University Press, Baltimore London, p 69–82

    Google Scholar 

  4. Lasagna L. This volume, P 45–49

    Google Scholar 

  5. Morris LA, Halperin JA (1979) Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health 69: 47–52

    Article  PubMed  CAS  Google Scholar 

  6. Selvini A (1976) Depression: a psychoterapeutic approach. In: Cassano GB, Lucchelli PE (eds) Psychosomatics and depression in general practice. Pozzi, Roma, p 10–17

    Google Scholar 

  7. Wheatley D (1973) Clinical Evaluation and Use of Drugs in General Practice. In: Jouhar AJ, Grayson MF (eds) International Aspects of Drug Evaluation and Usage. Churchill Livingstone, Edinburgh London, p 301–308

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lucchelli, P.E. (1985). Clinical trials and the general practitioner. In: Steichele, C., Abshagen, U., Koch-Weser, J. (eds) Drugs between Research and Regulations. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-54130-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54130-8_8

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-642-54132-2

  • Online ISBN: 978-3-642-54130-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics